$94.7 Million is the total value of INTERWEST VENTURE MANAGEMENT CO's 12 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
REAL | Sell | THE REALREAL | $36,130,000 | -71.4% | 5,154,080 | -23.1% | 38.16% | -29.9% |
GKOS | GLAUKOS CORP | $31,272,000 | -43.3% | 1,013,364 | 0.0% | 33.03% | +38.8% | |
MGNX | MACROGENICS INC | $6,253,000 | -46.5% | 1,074,316 | 0.0% | 6.60% | +31.1% | |
EIGR | EIGER BIOPHARMACEUTICALS INC | $5,201,000 | -54.4% | 764,918 | 0.0% | 5.49% | +11.8% | |
AGTC | APPLIED GENETIC TECHNOL CORP | $4,776,000 | -27.4% | 1,455,904 | 0.0% | 5.04% | +77.8% | |
CDTX | CIDARA THERAPEUTICS INC | $3,365,000 | -35.4% | 1,356,813 | 0.0% | 3.56% | +58.3% | |
KALV | KALVISTA PHARMACEUTICALS INC | $2,974,000 | -57.0% | 388,766 | 0.0% | 3.14% | +5.3% | |
VERO | VENUS CONCEPT INC | $2,338,000 | -24.5% | 658,657 | 0.0% | 2.47% | +85.0% | |
STIM | NEURONETICS INC | $1,948,000 | -57.9% | 1,030,689 | 0.0% | 2.06% | +3.2% | |
OBALON THERAPEUTICS INC | $274,000 | -62.0% | 380,224 | 0.0% | 0.29% | -7.1% | ||
XENE | XENON PHARMACEUTICALS INC | $94,000 | -13.8% | 8,293 | 0.0% | 0.10% | +110.6% | |
DARE | DARE BIOSCIENCE INC | $43,000 | +4.9% | 50,368 | 0.0% | 0.04% | +150.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-04-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
GLAUKOS CORP | 28 | Q3 2023 | 33.0% |
EIGER BIOPHARMACEUTICALS INC | 24 | Q3 2022 | 17.7% |
APPLIED GENETIC TECHNOL CORP | 24 | Q3 2022 | 6.7% |
XENON PHARMACEUTICALS INC | 20 | Q3 2021 | 0.6% |
CIDARA THERAPEUTICS INC | 19 | Q2 2021 | 4.5% |
THE REALREAL | 18 | Q3 2023 | 62.6% |
KALVISTA PHARMACEUTICALS INC | 17 | Q4 2020 | 10.8% |
DARE BIOSCIENCE INC | 16 | Q3 2023 | 0.3% |
MACROGENICS INC | 14 | Q1 2020 | 19.2% |
PMV PHARMACEUTICALS INC | 13 | Q3 2023 | 67.5% |
View INTERWEST VENTURE MANAGEMENT CO's complete holdings history.
Latest filings
Type | Filed |
---|---|
144 | 2024-02-27 |
13F-HR | 2023-10-20 |
13F-HR | 2023-07-21 |
13F-HR | 2023-04-27 |
13F-HR | 2023-01-31 |
13F-HR | 2022-10-25 |
13F-HR | 2022-08-02 |
13F-HR | 2022-04-13 |
13F-HR | 2022-01-25 |
13F-HR | 2021-10-19 |
View INTERWEST VENTURE MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.